POP technologies, INC., "multivalent QS-18 protein nanoparticles for a broadly protective influenza virus vaccine".
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00031
- Awardee
-
Pop Biotechnologies Inc. UEI ZWKMU75DGJY4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,806
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $599,806.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Amherst, NY 14228, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $599,806 firm fixed price definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Pop Biotechnologies Inc., a Buffalo, NY-based small disadvantaged business. The contract is for research and development of "Multivalent QS-18 Protein Nanoparticles for a Broadly Protective Influenza Virus Vaccine" and has a performance period ending on September 29, 2025. The contract was awarded on September 30, 2023 under the Small Business Innovation Research (SBIR) program, which aims to stimulate innovation and strengthen the role of small businesses in meeting federal research needs. Pop Biotechnologies has previously received SBIR contracts and grants from NIH and other agencies for work on influenza, HIV, and COVID-19 vaccines, as well as cancer therapies.
Quick answers
Who was awarded contract 75N93023C00031?
75N93023C00031 was awarded to Pop Biotechnologies Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2023.
How much is contract 75N93023C00031 worth?
The government has obligated $599,806 on 75N93023C00031.
Was contract 75N93023C00031 competed?
The extent of competition for 75N93023C00031 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award